Anticorps Phospholipase C gamma 1 + 2

6 produits

Phospholipase C gamma 1 + 2 est un gène codé par le symbole PLCG2. Communément appelé aussi: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2; Phosphoinositide phospholipase C-gamma-2; Phospholipase C-IV; PLC-IV; Phospholipase C-gamma-2; PLC-gamma-2; PLCG2. Phospholipase C gamma 1 + 2 a une masse de 147.87kDa, une longueur d'acide aminé de 1265, et est impliqué dans les maladies: Familial cold autoinflammatory syndrome 3; Autoinflammation, antibody deficiency, and immune dysregulation PLCG2-associated.

Nous proposons 6 des anticorps contre Phospholipase C gamma 1 + 2, élevé dans Lapin, qui sont appropriés pour le WB, IHC, ELISA et ICC/IF avec des échantillons dérivés de Humain, Souris et Rat.

Informations sur les Gènes et les Protéines

Résumé UniProt
The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. It is a crucial enzyme in transmembrane signaling.
Résumé Entrez
The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of receptor-mediated tyrosine kinase activators. For example, when activated by SRC, the encoded protein causes the Ras guanine nucleotide exchange factor RasGRP1 to translocate to the Golgi, where it activates Ras. Also, this protein has been shown to be a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase. Two transcript variants encoding different isoforms have been found for this gene.
Implication dans la maladie
Familial cold autoinflammatory syndrome 3: An autosomal dominant immune disorder characterized by the development of cutaneous urticaria, erythema, and pruritis in response to cold exposure. Affected individuals have variable additional immunologic defects, including antibody deficiency, decreased numbers of B-cells, defective B-cells, increased susceptibility to infection, and increased risk of autoimmune disorders.

Autoinflammation, antibody deficiency, and immune dysregulation PLCG2-associated: An autosomal dominant systemic disorder characterized by recurrent blistering skin lesions with a dense inflammatory infiltrate and variable involvement of other tissues, including joints, the eye, and the gastrointestinal tract. Affected individuals have a mild humoral immune deficiency associated with recurrent sinopulmonary infections, but no evidence of circulating autoantibodies.
Modification post-traductionnelle
Phosphorylated on tyrosine residues by CSF1R (By similarity). Phosphorylated on tyrosine residues by BTK and SYK; upon ligand-induced activation of a variety of growth factor receptors and immune system receptors. Phosphorylation leads to increased phospholipase activity.
Liens de base de données
Immunohistochemistry - Anti-PLCG1 Antibody (B0080) - Antibodies.com
(2)
Voir le roduitTaille d'Essai de 10µg
Western Blot - Anti-PLCG1 (phospho Tyr771) Antibody (A0079) - Antibodies.com
(5)
Voir le roduitTaille d'Essai de 10µg
Immunohistochemistry - Anti-PLCG1 Antibody (B0079) - Antibodies.com
(2)
Voir le roduitTaille d'Essai de 10µg
Western Blot - Anti-PLCG1 (phospho Tyr1253) Antibody (A0551) - Antibodies.com
Voir le roduitTaille d'Essai de 10µg
Immunofluorescence - Anti-PLCG1 Antibody (B0551) - Antibodies.com
Voir le roduitTaille d'Essai de 10µg
Antibodies.com Image Placeholder - Discover more for less
Voir le roduitTaille d'Essai de 10µg

Affichage de 1-6 sur 6 produits

Filtres Menu Principal Nous Contacter 0Caisse
Haut